Clinical Trials Sponsored by jiuwei cui

Total 751 results

jiuwei cui

Unknown

NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer.

Small Cell Lung Cancer

China
jiuwei cui

Unknown

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Leukemia, B-Cell
Xiumei Song

Recruiting

Effect of Ciprofol Infusion for Induction and Maintenance on Hemodynamics and Postoperative Recovery

Anesthesia | Hemodynamics | Postoperative Recovery

China
Jiawei Qin

Not yet recruiting

Application and Translational Research of 3D Printed in Treatment of Choledocholithiasis Under ERCP

Common Bile Duct Calculi
Yang Xinwei

Active, not recruiting

Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy

Focal Epilepsy

China
Xiumei Song

Not yet recruiting

Clinical Observation of Ciprofol for Anesthesia Induction

Pain | Anesthesia | Hemodynamic Instability
Xiumei Song

Not yet recruiting

Effect of Esmolol on Perioperative Stress Reaction

Airway Obstruction | Stress Reaction | Catecholamine; Overproduction | Esmolol
Da, Yuwei, M.D.

Recruiting

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Myasthenia Gravis

China
Da, Yuwei, M.D.

Recruiting

Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

Myasthenia Gravis

China
Junhui Cui
West China Hospital

Completed

A New Surgical Instrument in Treatment of Conlylar Fracture: Condylar Reductor

Mandibular Fracture
Jiawei Jiang

Recruiting

Percutaneous Vertebral-disc Plasty for Thoracolumbar Very Severe Osteoporotic Vertebral Compression Fractures

Osteoporotic Fracture of Vertebra

China
Cui Yimin

Unknown

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants

Pharmacokinetics | Pharmacodynamics | Apixaban | Pharmacogenomics | Accurate Medication | Rivaroxaban | Novel Oral Anticoagulants | NOACs | Dabigatran

China
Cui Yimin

Unknown

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor

Pharmacokinetics | Pharmacodynamics | Pharmacogenomics | Accurate Medication | Ticagrelor

China
Cui Yimin

Unknown

Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention

Coronary Heart Disease | Percutaneous Coronary Intervention | Restenosis | Clopidogrel | Smoking Status | Genetic Risk Factors

China
Cui Yimin

Unknown

Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Solid Tumors | Pharmacogenetics | Docetaxel

China
Cui Yimin

Unknown

miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment

Breast Cancer

China
Jikei University School of Medicine

Unknown

A Morbidity-Mortality and Remodeling Study With Valsartan

Hypertension | Ischemic Heart Disease | Congestive Heart Failure

Japan
Xuzhou Third People's Hospital
Shandong Jiwei Medical Products Co., Ltd

Recruiting

OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS) (EXPECT)

Non ST Segment Elevation Myocardial Infarction | Unstable Anginas

China
Cui Yimin

Recruiting

Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants：A Study on Behavioral Patterns

Behavioral Symptoms | Anticoagulants | Intention

China
Cui Yimin

Unknown

Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation

Compliance, Medication | Anticoagulants

China
Cui Yimin

Unknown

A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive Patients.

Stroke | Pharmacogenomics | Enalapril Adverse Reaction

China
Cui Yimin

Unknown

A Research in Pharmacogenomics and Accurate Medication of Risperidone

Schizophrenia | Mental Illness

China
Cui Yimin

Unknown

Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Solid Tumor | Pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Capecitabine | Pharmacogenetics

China
Cui Yimin

Unknown

A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction

Simvastatin Adverse Reaction | Pharmacogenomics | Accurate Medication

China
Junwei Hao

Completed

Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome

GBS

China
Jieqiong Cui

Not yet recruiting

A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression

Depressive Disorder | Mental Disorder in Adolescence
Cui Xulei

Completed

Continuous Paravertebral Block on Postoperative Quality of Recovery After Hepatectomy

Nerve Block

China
Cui Xulei

Terminated

TMQLB Versus TPVB for Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

Nerve Block, Nephrectomy, Analgesia

China
Cui Xulei

Terminated

Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

Analgesia | Hepatectomy | Nerve Block

China
Cui Xulei

Completed

Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain of Hepatectomy With Right J-shape Subcostal Incision

Analgesia | Hepatectomy | Nerve Block

China
Cui Xulei

Completed

CTPVB for Hepatectomy

Hepatectomy | Pain Management | Paravertebral Block

China
Cui Xulei

Completed

Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

Pain Management | Laparoscopic Renal Surgery | Nerve Block

China
Cui Xulei

Completed

Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy

Analgesia | Hepatectomy | Paravertebral Block | Postoperative Recovery

China
Cui Xulei

Completed

QLB Versus PVB for Acute Pain and Quality of Recovery After Laparoscopic Partial Nephrectomy

Nerve Block, Nephrectomy, Analgesia

China
Cui Xulei

Completed

TQLB for Postoperative Pain After Laparoscopic Partial Nephrectomy

Pain Management | Laparoscopic Renal Surgery | Nerve Block

China
CTI BioPharma

Completed

Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

Acute Myelogenous Leukemia

United States
CTI BioPharma

Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant (PIX-R)

Diffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 Lymphoma

United States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
CTI BioPharma

Terminated

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. (PIONEER)

NSCLC

United States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
CTI BioPharma

Terminated

Arsenic Trioxide in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
CTI BioPharma

Terminated

Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

Canada, United States
CTI BioPharma

Terminated

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom
CVI Pharmaceuticals

Unknown

Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia

Hyperlipidemia

China
CTI BioPharma

Completed

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin (RAPID)

Diffuse Large-Cell Lymphoma

United States, Germany, Canada, Italy, France
CTI BioPharma

Completed

Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer

Colorectal Cancer

Italy
Ling Cui

Completed

Fast-track Surgery After Gynecological Oncology Surgery

Postoperative Complications | Length of Stay | CRP

China
Cui xuejun

Unknown

The Efficacy of the Traditional Chinese Medicine Fangji Huangqi Pill Combined With Mobic on Active Knee Osteoarthritis

Knee Osteoarthritis | Fangji Huangqi Pill

China
Cue Biopharma

Recruiting

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer

United States
CTI BioPharma

Withdrawn

Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment (Hepatic)

Metastatic Cancer

United States
CTI BioPharma

Completed

Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib

Primary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post- Essential Thrombocythemia Myelofibrosis

United States, Spain, United Kingdom, Hungary, Korea, Republic of, France, Italy, Sweden
CTI BioPharma

Withdrawn

Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

Lymphoma | Leukemia

United States

Clinical Trials Sponsored by jiuwei cui

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations